Description
The study shows that tau mutations disrupt TREM2/TYROBP networks in microglia, but the mechanistic pathway connecting mutant tau to this critical microglial signaling disruption remains unexplained. Understanding this mechanism is crucial since TREM2/TYROBP dysfunction is implicated across multiple neurodegenerative diseases.
Gap type: unexplained_observation Source paper: Cell autonomous microglia defects in a stem cell model of frontotemporal dementia tau. (None, None, PMID:40527900)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:43.316699+00:00”, “resolution_summary”: “Resolved by hypothesis h-var-f1f624c111: TREM2-Mediated Senescent Microglial Reprogramming of Astrocyte Networks. Supporting evidence includes debate sess_SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-var-f1f624c111”, “title”: “TREM2-Mediated Senescent Microglial Reprogramming of Astrocyte Networks”, “score”: 0.369, “reason”: “9 token overlaps; entity overlap: trem2, tyrobp”, “analysis_id”: “SDA-BIOMNI-SPATIAL_-c2b61633”, “target_gene”: “TREM2”, “target_pathway”: “TREM2/TYROBP → microglial senescence → astrocyte network reprogramming”, “disease”: “neurodegeneration”, “composite_score”: 0.38, “confidence_score”: 0.715, “status”: “promoted”, “pubmed_evidence_ids”: [“20301376”, “24047521”, “28802038”, “30258234”, “31932797”]}, {“id”: “h-var-fb974d4b65”, “title”: “TREM2-Mediated Oligodendrocyte Metabolic Support in White Matter Neurodegeneration”, “score”: 0.355, “reason”: “8 token overlaps; entity overlap: trem2, tyrobp”, “analysis_id”: “SDA-2026-04-26-trem2-showcase”, “target_gene”: “TREM2”, “target_pathway”: “TREM2/TYROBP microglial signaling → oligodendrocyte metabolic support”, “disease”: “neurodegeneration”, “composite_score”: 0.38, “confidence_score”: 0.715, “status”: “proposed”, “pubmed_evidence_ids”: [“20301376”, “24047521”, “28802038”, “30258234”, “31932797”]}, {“id”: “h-85b51a8f58”, “title”: “Microglial TREM2 state determines whether C1q-tagged substrates are cleared adaptively or converted into chronic complement-associated synaptotoxic inflammation”, “score”: 0.354, “reason”: “5 token overlaps; entity overlap: trem2, tyrobp”, “analysis_id”: “SDA-2026-04-25-gapdebate-afba1a80bd”, “target_gene”: “TREM2,TYROBP,C1QA,C1QB,C1QC,C3”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.67, “confidence_score”: 0.71, “status”: “proposed”, “pubmed_evidence_ids”: [“28602351”, “32579671”, “33516818”, “36306735”, “37442133”]}, {“id”: “SDA-2026-04-16-hyp-f460e747”, “title”: “Selective Microglial Senescence Targeting via TREM2 Modulation”, “score”: 0.351, “reason”: “20 token overlaps; entity overlap: trem2, tyrobp”, “analysis_id”: “SDA-2026-04-04-gap-senescent-clearance-neuro”, “target_gene”: “TREM2”, “target_pathway”: “TREM2/TYROBP microglial signaling”, “disease”: null, “composite_score”: 0.459, “confidence_score”: 0.29, “status”: “proposed”, “pubmed_evidence_ids”: [“28802038”, “30266932”, “33516818”]}, {“id”: “h-0ca0f0f8f2”, “title”: “TREM2 Deficiency Drives Microglial Senescence via Lipid Metabolism Dysregulation”, “score”: 0.349, “reason”: “21 token overlaps; entity overlap: trem2, tyrobp”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-041439-5f43216e”, “target_gene”: “TREM2/TYROBP”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.818246, “confidence_score”: 0.82, “status”: “debated”, “pubmed_evidence_ids”: [“29130303”, “31182953”, “31942086”, “41674808”, “41690475”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c”, “title”: “The abstract shows TYROBP deficiency is neuroprotective despite being required for TREM2, CD33, and CR3 function - receptors associated with AD risk. This counterintuitive finding challenges current understanding of how these immune receptors contribute to AD pathogenesis.\n\nGap type: contradiction\nSource paper: Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology. (None, None, PMID:28612290)”, “score”: 0.626, “reason”: “10 token overlaps; entity overlap: pmid, trem2, tyrobp”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c”, “quality_score”: 0.56, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88_20260413-225852”, “title”: “The study shows VCP-mutant astrocytes exhibit hypoxia response activation without actual hypoxia, but the mechanistic link between VCP dysfunction and HIF-1α stabilization remains unexplained. Understanding this connection is critical for developing targeted therapies that could prevent early pathogenic events in VCP-ALS.\n\nGap type: unexplained_observation\nSource paper: Hypoxic stress is an early pathogenic event in human VCP-mutant ALS astrocytes. (2026, Stem cell reports, PMID:41349534)”, “score”: 0.52, “reason”: “16 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-145358-185db2c8_20260414-005137”, “title”: “The study shows homozygous R136S fully rescues APOE4-driven pathology while heterozygous provides only partial protection, but the mechanistic basis for this gene dosage effect is unexplained. Understanding this mechanism is critical for developing therapeutic strategies that could mimic R136S protection.\n\nGap type: unexplained_observation\nSource paper: The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. (2023, Nature neuroscience, PMID:37957317)”, “score”: 0.484, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-145358-185db2c8”, “quality_score”: 0.81, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5_20260413-235122”, “title”: “The study shows that MCT1 disruption leads to axon degeneration and neuron death, but the specific molecular pathways linking lactate transport dysfunction to neuronal damage remain unexplained. Understanding this mechanism is critical for developing targeted neuroprotective therapies.\n\nGap type: unexplained_observation\nSource paper: Oligodendroglia metabolically support axons and contribute to neurodegeneration. (2012, Nature, PMID:22801498)”, “score”: 0.463, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5”, “quality_score”: 0.82, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5_20260414-001952”, “title”: “The study shows that MCT1 disruption leads to axon degeneration and neuron death, but the specific molecular pathways linking lactate transport dysfunction to neuronal damage remain unexplained. Understanding this mechanism is critical for developing targeted neuroprotective therapies.\n\nGap type: unexplained_observation\nSource paper: Oligodendroglia metabolically support axons and contribute to neurodegeneration. (2012, Nature, PMID:22801498)”, “score”: 0.463, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}